Bruce N. Jacobs - Jun 27, 2024 Form 4 Insider Report for Kymera Therapeutics, Inc. (KYMR)

Role
Chief Financial Officer
Signature
/s/ Bruce N. Jacobs
Stock symbol
KYMR
Transactions as of
Jun 27, 2024
Transactions value $
$52,000
Form type
4
Date filed
6/28/2024, 08:30 AM
Previous filing
Mar 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KYMR Common Stock Options Exercise $52K +25K +17.42% $2.08* 169K Jun 27, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KYMR Stock Option (Right to Buy) Options Exercise $0 -25K -19.25% $0.00 105K Jun 27, 2024 Common Stock 25K $2.08 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This number includes 1,203 shares acquired under the Registrant's employee stock purchase plan on June 1, 2024.
F2 Twenty-five percent (25%) of the shares underlying this stock option vested on July 1, 2020 and the remaining shares shall vest in equal monthly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date.